Published in World J Nephrol on September 06, 2015
Multi-modality imaging review of congenital abnormalities of kidney and upper urinary tract. World J Radiol (2016) 0.88
Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease. PLoS One (2016) 0.75
Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease. PLoS One (2016) 0.75
Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus. Can J Kidney Health Dis (2017) 0.75
Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2012) 9.88
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2013) 3.83
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol (2010) 3.47
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2011) 2.43
Sirolimus therapy to halt the progression of ADPKD. J Am Soc Nephrol (2010) 2.42
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int (2005) 2.32
Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology (2004) 2.14
Occult intracranial aneurysms in polycystic kidney disease. When is cerebral arteriography indicated? N Engl J Med (1983) 2.12
Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med (2014) 2.06
Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study. Am J Kidney Dis (2011) 2.05
Autosomal dominant polycystic kidney disease. Am Fam Physician (2014) 1.97
Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol (2011) 1.65
Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2007) 1.65
The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol (2010) 1.59
Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation. Transplantation (2012) 1.54
Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int (2011) 1.53
One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2012) 1.47
Autosomal dominant polycystic kidney disease and pain - a review of the disease from aetiology, evaluation, past surgical treatment options to current practice. J Postgrad Med (2004) 1.46
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Am J Kidney Dis (2011) 1.39
Changing referral characteristics of patients with autosomal dominant polycystic kidney disease. Am J Med (2013) 1.34
Laparoscopic bilateral synchronous nephrectomy for autosomal dominant polycystic kidney disease: the initial experience. J Urol (2001) 1.34
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol (2008) 1.33
Pain management in polycystic kidney disease. Kidney Int (2001) 1.31
Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 1.22
Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark. Clin J Am Soc Nephrol (2010) 1.19
Coronary aneurysms in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1998) 1.16
CAPD in patients with autosomal dominant polycystic kidney disease. Perit Dial Int (1999) 1.16
Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 1.11
Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis. Neurosurgery (1996) 1.10
Pain patterns in patients with polycystic kidney disease. Kidney Int (2004) 1.08
Renal and extrarenal manifestations of autosomal dominant polycystic kidney disease. Braz J Med Biol Res (2006) 1.06
Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant (2011) 1.06
Management of ESRD in patients with autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 1.03
End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol (2005) 1.00
Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects. Nephron Clin Pract (2011) 1.00
Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease. Ann R Coll Surg Engl (2011) 0.98
The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease. Ann Transplant (1996) 0.97
Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation. Transplant Proc (2009) 0.97
The spectrum of polycystic kidney disease in children. Adv Chronic Kidney Dis (2011) 0.96
Transperitoneal laparoscopic nephrectomy for giant polycystic kidneys: a case control study. Urology (2001) 0.96
Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2013) 0.94
Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS (2013) 0.93
Spontaneous coronary artery dissection in a woman with polycystic kidney disease. Am J Kidney Dis (2008) 0.92
Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation (2007) 0.90
Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation? BJU Int (2010) 0.90
Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study. BMC Nephrol (2013) 0.90
The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre. QJM (2013) 0.90
Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study. Clin J Am Soc Nephrol (2014) 0.90
Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant (2013) 0.90
Concomitant nephrectomy of massively enlarged kidneys and renal transplantation in autosomal dominant polycystic kidney disease. Transplant Proc (2005) 0.89
Defective metabolism in polycystic kidney disease: potential for therapy and open questions. Nephrol Dial Transplant (2014) 0.89
Simultaneous renal transplantation and native nephrectomy in patients with autosomal-dominant polycystic kidney disease. Transplant Proc (2007) 0.88
Renal transplantation in autosomal dominant polycystic kidney disease. Nat Rev Nephrol (2014) 0.88
Cardiovascular complications in autosomal dominant polycystic kidney disease. Curr Hypertens Rev (2013) 0.86
Bilateral open transperitoneal cyst reduction surgery for autosomal dominant polycystic kidney disease. J Urol (1998) 0.86
Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol (2012) 0.86
Pharmacological management of polycystic kidney disease. Expert Opin Pharmacother (2014) 0.86
Efficacy and safety of mTOR inhibitor therapy in patients with early-stage autosomal dominant polycystic kidney disease: a meta-analysis of randomized controlled trials. Am J Med Sci (2012) 0.86
Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease. Med Hypotheses (2009) 0.85
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2013) 0.84
Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms? AJNR Am J Neuroradiol (2013) 0.83
New modalities for evaluation and surveillance of complex renal cysts. J Urol (2014) 0.83
A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant (2014) 0.82
Better understanding of ADPKD results in potential new treatment options: ready for the cure? J Nephrol (2008) 0.82
Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective. Int J Nephrol Urol (2010) 0.82
Autosomal dominant policystic kidney disease, more than a renal disease. Minerva Endocrinol (2014) 0.82
Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study. Nephron Clin Pract (2011) 0.81
Transcatheter renal artery embolization improves lung function in patients with autosomal dominant polycystic kidney disease on hemodialysis. Clin Exp Nephrol (2012) 0.81
Review of tolvaptan for autosomal dominant polycystic kidney disease. Pharmacotherapy (2014) 0.81
Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry. BMC Nephrol (2013) 0.80
Autosomal-dominant polycystic kidney disease: high prevalence of graft loss for death-related malignancies and cardiovascular risk factors. Transplant Proc (2003) 0.80
Sirolimus for treatment of autosomal-dominant polycystic kidney disease: a meta-analysis of randomized controlled trials. Transplant Proc (2014) 0.80
Spanish guidelines for the management of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2014) 0.80
Concurrent unilateral or bilateral native nephrectomy in kidney transplant recipients. Ann Transplant (2013) 0.80
Dissecting aneurysm in a patient with autosomal dominant polycystic kidney disease. Ann Thorac Cardiovasc Surg (2012) 0.80
Polycystic diseases in visceral organs. Obstet Gynecol Int (2011) 0.79
Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta-analysis of randomized trials. Nephrology (Carlton) (2014) 0.79
Exploring urinary biomarkers in autosomal dominant polycystic kidney disease. Clin Exp Nephrol (2014) 0.78
Simultaneous transabdominal bilateral nephrectomy in potential kidney transplant recipients. Transplant Proc (2006) 0.78
Retroperitoneoscopic management of infected cysts in adult polycystic kidney disease. Urol Int (1999) 0.78
Berberine slows cell growth in autosomal dominant polycystic kidney disease cells. Biochem Biophys Res Commun (2013) 0.78
Long-term treatment with mammalian target of rapamycin inhibitor does not benefit patients with autosomal dominant polycystic kidney disease: a meta-analysis. Nephron Clin Pract (2013) 0.78
Simultaneous kidney transplantation and bilateral native nephrectomy for polycystic kidney disease. J Urol (2013) 0.78
Left ventricular hypertrophy in ADPKD: changing demographics. Curr Hypertens Rev (2013) 0.77
A follow-up study of autosomal dominant polycystic kidney disease with intracranial aneurysms using 3.0 T three-dimensional time-of-flight magnetic resonance angiography. Eur J Radiol (2013) 0.77
Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease. PLoS One (2013) 0.77
Management of chronic pain in a patient with autosomal dominant polycystic kidney disease by sequential celiac plexus blockade, radiofrequency ablation, and spinal cord stimulation. Am J Kidney Dis (2012) 0.77
Effects of combined administration of rapamycin, tolvaptan, and AEZ-131 on the progression of polycystic disease in PCK rats. Am J Physiol Renal Physiol (2014) 0.77
Kidney transplant for autosomal dominant polycystic kidney disease: the superiority of concurrent bilateral nephrectomy. Urol Int (2011) 0.77
Blood pressure and intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Blood Press Res (2014) 0.77
The Roles of Primary cilia in Polycystic Kidney Disease. AIMS Mol Sci (2015) 0.77
Rationale and design of an observational study to determine the effects of cholecalciferol on hypertension, proteinuria and urinary MCP-1 in ADPKD. Curr Hypertens Rev (2013) 0.77
Refractory Salmonella enterica serotype choleraesuis-related renal cyst infection in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis treated successfully with intracystic ciprofloxacin infusion. Med Princ Pract (2012) 0.76
Surgical cyst decortication in autosomal dominant polycystic kidney disease. J Endourol (2013) 0.76
Renal transplant in patients with polycystic disease: the Italian experience. Transplant Proc (2013) 0.76
Therapeutic advances in the treatment of polycystic kidney disease. Nephron Clin Pract (2015) 0.76
(67)Ga SPECT/CT accurately localized recurrent hepatic cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Nucl Med (2014) 0.76
Urinary tract infections in polycystic kidney disease. Med Arh (2011) 0.76
Multiple cardiovascular manifestations in a patient with autosomal dominant polycystic kidney disease. J Cardiovasc Ultrasound (2014) 0.76
Peritoneal dialysis associated infections: An update on diagnosis and management. World J Nephrol (2012) 1.02
Transplant nephrectomy. World J Transplant (2011) 0.95
Key issues in transplant tourism. World J Transplant (2012) 0.78
Kidney donation after cardiac death. World J Nephrol (2012) 0.75